Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation
Jones J, Shepherd J, Baxter L, Gospodarevskaya E, Hartwell D, Harris P, Price A
Record ID 32008100365
English
Authors' recommendations:
Study found that both adefovir dipivoxil and pegylated interferon alpha are beneficial for patients with chronic hepatitis B in terms of suppressing viral load, reducing liver damage-associated biochemical activity, inducing HBeAg seroconversion, and reducing liver fibrosis and necroinflammation
Details
Project Status:
Completed
URL for project:
http://www.hta.ac.uk/1718
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Adult
- Aged
- Female
- Male
- Middle Aged
- Adenine
- Antiviral Agents
- Hepatitis B, Chronic
- Interferon-alpha
- Organophosphonates
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2009 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.